🇺🇸 FDA
Patent

US 10035832

HLA-A24 agonist epitopes of MUC1-C oncoprotein and compositions and methods of use

granted A61KA61K2039/53A61K2039/55588

Quick answer

US patent 10035832 (HLA-A24 agonist epitopes of MUC1-C oncoprotein and compositions and methods of use) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jul 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Jul 31 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K2039/53, A61K2039/55588, A61K2239/31, A61K31/00